Partner Content Partner Content How Will Spark’s Approval Impact the Gene Therapy Field? Gene Therapy for Rare Disorders Summit
Events Partner Content 3rd Annual Medical Device Project and Portfolio Management This two-day event guarantees top notch networking
News Aimmune to file peanut allergy treatment by year-end Backed by a $202 million fundraiser, biotech Aimmune has announced plans to file its potential peanut allergy treatment at the end of the year following a phase 3 trial success.
Oncology Getting predictive technologies to patients, with Concr Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
